Epigenetic Modulation with 5-Aza-CdR Prevents Metabolic-Associated Fatty Liver Disease Promoted by Maternal Overnutrition
Nutrients · 2024
DOI: 10.3390/nu17010106 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Henghui Cheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, Texas A&M University, College Station, TX 77843, USA. Hauptthemen laut MEDLINE: Overnutrition, Epigenesis, Genetic, Decitabine, Maternal Nutritional Physiological Phenomena. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, USDA Hatch project.
Abstract (Originalsprache)
Background/Objectives: This study builds on previous findings from mouse models, which showed that maternal overnutrition induced by a high-fat diet (HFD) promotes metabolic-associated fatty liver disease (MAFLD) in offspring, linked to global DNA hypermethylation. We explored whether epigenetic modulation with 5-Aza-CdR, a DNA methylation inhibitor, could prevent MAFLD in offspring exposed to maternal overnutrition.
Methods
The offspring mice from dams of maternal overnutrition were fed either a chow diet or a high-fat diet (HFD) for 10 weeks. These mice were randomly divided into two groups: HFD, and AZA + HFD. Mice assigned to the AZA group were given 5-Aza-CdR during the last three weeks.
Results
Our findings show that 5-Aza-CdR treatment in HFD-fed offspring effectively countered weight gain, improved glucose regulation, and minimized hepatic fat buildup along with serum lipid imbalances. Additionally, it boosted AMPK signaling and raised PPAR-α expression, pointing to enhanced fatty acid oxidation. We also detected an increase in JNK signaling, affecting the gene expression associated with cell death and proliferation. Notably, treated mice displayed more hepatic inflammation than the HFD group alone, suggesting a complex, dual impact on MAFLD management. Significant apoptotic and inflammatory gene changes were identified, along with corresponding differentially methylated regions triggered by 5-Aza-CdR, marking potential therapeutic targets.
Conclusions
5-Aza-CdR was shown to mitigate MAFLD features in offspring of maternal overnutrition by reversing DNA hypermethylation and improving metabolic pathways, though its dual impact on inflammation highlights the need for further research to optimize its therapeutic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition, Texas A&M University, College Station, TX 77843, USA.
- Center for Epigenetics & Disease Prevention, Institute of Biosciences & Technology, College of Medicine, Texas A&M University, Houston, TX 77030, USA.
- Department of Statistics, Texas A&M University, College Station, TX 77843, USA.
ORCID-Profile: Jie Wu
Förderung
- NIDDK NIH HHS
- USDA Hatch project
Zitieren
APA
Cheng, H., Wu, J., Peng, H., Li, J., Liu, Z., Wang, X., Zhang, K., & Xie, L. (2024). Epigenetic Modulation with 5-Aza-CdR Prevents Metabolic-Associated Fatty Liver Disease Promoted by Maternal Overnutrition. Nutrients. https://doi.org/10.3390/nu17010106
Vancouver
Cheng H, Wu J, Peng H, Li J, Liu Z, Wang X, et al. Epigenetic Modulation with 5-Aza-CdR Prevents Metabolic-Associated Fatty Liver Disease Promoted by Maternal Overnutrition. Nutrients. 2024. doi:10.3390/nu17010106
BibTeX
@article{Cheng2024,
author = {Cheng, Henghui and Wu, Jie and Peng, Hui and Li, Jiangyuan and Liu, Zhimin and Wang, Xian and Zhang, Ke and Xie, Linglin},
title = {Epigenetic Modulation with 5-Aza-CdR Prevents Metabolic-Associated Fatty Liver Disease Promoted by Maternal Overnutrition},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu17010106}
}
EUVIMED